General Information of the Protein
Protein ID
PT03105
Protein Name
Receptor-interacting serine/threonine-protein kinase 3
Secondarily
Protein Name
RIP-like protein kinase 3
Receptor-interacting protein 3
Gene Name
RIPK3
Secondarily
Gene Name
RIP3
Sequence
MSCVKLWPSGAPAPLVSIEELENQELVGKGGFGTVFRAQHRKWGYDVAVKIVNSKAISREVKAMASLDNEFVLRLEGVIEKVNWDQDPKPALVTKFMENGSLSGLLQSQCPRPWPLLCRLLKEVVLGMFYLHDQNPVLLHRDLKPSNVLLDPELHVKLADFGLSTFQGGSQSGTGSGEPGGTLGYLAPELFVNVNRKASTASDVYSFGILMWAVLAGREVELPTEPSLVYEAVCNRQNRPSLAELPQAGPETPGLEGLKELMQLCWSSEPKDRPSFQECLPKTDEVFQMVENNMNAAVSTVKDFLSQLRSSNRRFSIPESGQGGTEMDGFRRTIENQHSRNDVMVSEWLNKLNLEEPPSSVPKKCPSLTKRSRAQEEQVPQAWTAGTSSDSMAQPPQTPETSTFRNQMPSPTSTGTPSPGPRGNQGAERQGMNWSCRTPEPNPVTGRPLVNIYNCSGVQVGDNNYLTMQQTTALPTWGLAPSGKGRGLQHPPPVGSQEGPKDPEAWSRPQGWYNHSGK
    Show/Hide
Organism
Homo sapiens, Human
Protein Classification
Enzyme
>
Kinase
>
Protein Kinase
>
TKL protein kinase group
Function
Serine/threonine-protein kinase that activates necroptosis and apoptosis, two parallel forms of cell death (PubMed:19524512, PubMed:19524513, PubMed:22265413, PubMed:22265414, PubMed:22421439, PubMed:29883609, PubMed:32657447). Necroptosis, a programmed cell death process in response to death-inducing TNF-alpha family members, is triggered by RIPK3 following activation by ZBP1 (PubMed:19524512, PubMed:19524513, PubMed:22265413, PubMed:22265414, PubMed:22421439, PubMed:29883609, PubMed:32298652). Activated RIPK3 forms a necrosis-inducing complex and mediates phosphorylation of MLKL, promoting MLKL localization to the plasma membrane and execution of programmed necrosis characterized by calcium influx and plasma membrane damage (PubMed:19524512, PubMed:19524513, PubMed:22265413, PubMed:22265414, PubMed:22421439, PubMed:25316792, PubMed:29883609). In addition to TNF-induced necroptosis, necroptosis can also take place in the nucleus in response to orthomyxoviruses infection: following ZBP1 activation, which senses double-stranded Z-RNA structures, nuclear RIPK3 catalyzes phosphorylation and activation of MLKL, promoting disruption of the nuclear envelope and leakage of cellular DNA into the cytosol (By similarity). Also regulates apoptosis: apoptosis depends on RIPK1, FADD and CASP8, and is independent of MLKL and RIPK3 kinase activity (By similarity). Phosphorylates RIPK1: RIPK1 and RIPK3 undergo reciprocal auto- and trans-phosphorylation (PubMed:19524513). In some cell types, also able to restrict viral replication by promoting cell death-independent responses (By similarity). In response to Zika virus infection in neurons, promotes a cell death-independent pathway that restricts viral replication: together with ZBP1, promotes a death-independent transcriptional program that modifies the cellular metabolism via up-regulation expression of the enzyme ACOD1/IRG1 and production of the metabolite itaconate (By similarity). Itaconate inhibits the activity of succinate dehydrogenase, generating a metabolic state in neurons that suppresses replication of viral genomes (By similarity). RIPK3 binds to and enhances the activity of three metabolic enzymes: GLUL, GLUD1, and PYGL (PubMed:19498109). These metabolic enzymes may eventually stimulate the tricarboxylic acid cycle and oxidative phosphorylation, which could result in enhanced ROS production (PubMed:19498109).
    Show/Hide
Uniprot ID
Primary ID:
Q9Y572

Secondarily ID:
B4DJL9
C4AM87
Q5J795
Q5J796
Q6P5Y1
    Show/Hide
HGNC ID
HGNC:10021
Subcellular Location
Cytoplasm
Cytosol
Nucleus
Map of Molecular Bioactivity Related to the Protein
Map of Molecular Bioactivity Related to the Protein

Protein
Cell Line
Compound

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Protein
Cell Line ID: CL000013 , Sf9
Compound ID Compound Name Compound Formula
CP0573274
6-(4-methylpiperazin-1-yl)-3-pyridin-4-yl-2-(3-thiophen-2-ylphenyl)imidazo[1,2-b]pyridazine
   Show/Hide
C26H24N6S
 1
1
IC50 = 270 nM
   TI
   LI
   LO
   TS
CP0542612
6-(4-methylpiperazin-1-yl)-3-pyridin-4-yl-2-(3-thiophen-3-ylphenyl)imidazo[1,2-b]pyridazine
   Show/Hide
C26H24N6S
 1
1
IC50 = 300 nM
   TI
   LI
   LO
   TS
CP0573275
6-(4-methylpiperazin-1-yl)-2-(3-phenylphenyl)-3-pyridin-4-ylimidazo[1,2-b]pyridazine
   Show/Hide
C28H26N6
 1
1
IC50 = 450 nM
   TI
   LI
   LO
   TS
CP0460257
6-(4-methylpiperazin-1-yl)-2-naphthalen-1-yl-3-pyridin-4-ylimidazo[1,2-b]pyridazine
   Show/Hide
C26H24N6
 1
1
IC50 = 880 nM
   TI
   LI
   LO
   TS
CP0566989
2-(6-methoxynaphthalen-1-yl)-6-(4-methylpiperazin-1-yl)-3-pyridin-4-ylimidazo[1,2-b]pyridazine
   Show/Hide
C27H26N6O
 1
1
IC50 = 1200 nM
   TI
   LI
   LO
   TS
CP0573810
2-(6-ethoxynaphthalen-1-yl)-6-(4-methylpiperazin-1-yl)-3-pyridin-4-ylimidazo[1,2-b]pyridazine
   Show/Hide
C28H28N6O
 1
1
IC50 = 1700 nM
   TI
   LI
   LO
   TS
CP0472620
2-(1,3-benzodioxol-4-yl)-6-(4-methylpiperazin-1-yl)-3-pyridin-4-ylimidazo[1,2-b]pyridazine
   Show/Hide
C23H22N6O2
 1
1
IC50 = 2500 nM
   TI
   LI
   LO
   TS
CP0402823
2-(1,3-benzodioxol-4-yl)-3-pyridin-4-ylimidazo[1,2-b]pyridazine
   Show/Hide
C18H12N4O2
 1
1
IC50 = 5500 nM
   TI
   LI
   LO
   TS
CP0552338
2-(1,3-benzodioxol-5-yl)-6-(4-methylpiperazin-1-yl)-3-pyridin-4-ylimidazo[1,2-b]pyridazine
   Show/Hide
C23H22N6O2
 1
1
IC50 = 7600 nM
   TI
   LI
   LO
   TS
CP0381495
2-(1,3-benzodioxol-4-yl)-6-(4-methylpiperazin-1-yl)-3-pyridin-3-ylimidazo[1,2-b]pyridazine
   Show/Hide
C23H22N6O2
 1
1
IC50 > 10000 nM
   TI
   LI
   LO
   TS
CP0381496
2-(2,3-dihydro-1,4-benzodioxin-6-yl)-6-(4-methylpiperazin-1-yl)-3-pyridin-4-ylimidazo[1,2-b]pyridazine
   Show/Hide
C24H24N6O2
 1
1
IC50 > 10000 nM
   TI
   LI
   LO
   TS
CP0381509
6-(4-methylpiperazin-1-yl)-2-(5-phenylthiophen-2-yl)-3-pyridin-4-ylimidazo[1,2-b]pyridazine
   Show/Hide
C26H24N6S
 1
1
IC50 > 10000 nM
   TI
   LI
   LO
   TS
CP0385538
[4-[6-(4-methylpiperazin-1-yl)-3-pyridin-4-ylimidazo[1,2-b]pyridazin-2-yl]phenyl]-morpholin-4-ylmethanone
   Show/Hide
C27H29N7O2
 1
1
IC50 > 10000 nM
   TI
   LI
   LO
   TS
CP0402824
2-(2,3-dihydro-1,4-benzodioxin-5-yl)-6-(4-methylpiperazin-1-yl)-3-pyridin-4-ylimidazo[1,2-b]pyridazine
   Show/Hide
C24H24N6O2
 1
1
IC50 > 10000 nM
   TI
   LI
   LO
   TS
CP0441494
2-(1,3-benzodioxol-4-yl)-6-(4-methylpiperazin-1-yl)-3-phenylimidazo[1,2-b]pyridazine
   Show/Hide
C24H23N5O2
 1
1
IC50 > 10000 nM
   TI
   LI
   LO
   TS
CP0487013
6-(4-methylpiperazin-1-yl)-2-(4-phenylphenyl)-3-pyridin-4-ylimidazo[1,2-b]pyridazine
   Show/Hide
C28H26N6
 1
1
IC50 > 10000 nM
   TI
   LI
   LO
   TS
CP0487014
2-(3-methoxyphenyl)-6-(4-methylpiperazin-1-yl)-3-pyridin-4-ylimidazo[1,2-b]pyridazine
   Show/Hide
C23H24N6O
 1
1
IC50 >= 10000 nM
   TI
   LI
   LO
   TS
CP0527429
[3-[6-(4-methylpiperazin-1-yl)-3-pyridin-4-ylimidazo[1,2-b]pyridazin-2-yl]phenyl]-morpholin-4-ylmethanone
   Show/Hide
C27H29N7O2
 1
1
IC50 > 10000 nM
   TI
   LI
   LO
   TS
CP0547247
6-[6-(4-methylpiperazin-1-yl)-3-pyridin-4-ylimidazo[1,2-b]pyridazin-2-yl]-1,3-benzothiazole
   Show/Hide
C23H21N7S
 1
1
IC50 > 10000 nM
   TI
   LI
   LO
   TS
CP0573783
2-(1,3-benzodioxol-4-yl)-6-(4-methylpiperazin-1-yl)-3-pyridin-4-ylimidazo[1,2-a]pyridine
   Show/Hide
C24H23N5O2
 1
1
IC50 > 10000 nM
   TI
   LI
   LO
   TS
CP0001550
1-hydroxy-3-(1-methylindol-3-yl)-4-(1-propan-2-ylindol-3-yl)pyrrole-2,5-dione
   Show/Hide
C24H21N3O3
 1
1
IC50 > 10000 nM
   TI
   LI
   LO
   TS
CP0001850
6-[3-[1-hydroxy-4-(1-methylindol-3-yl)-2,5-dioxopyrrol-3-yl]indol-1-yl]hexanenitrile
   Show/Hide
C27H24N4O3
 1
1
IC50 > 10000 nM
   TI
   LI
   LO
   TS
CP0002105
6-[3-[1-hydroxy-4-(1-methylindol-3-yl)-2,5-dioxopyrrol-3-yl]indol-1-yl]hexanoic acid
   Show/Hide
C27H25N3O5
 1
1
IC50 > 10000 nM
   TI
   LI
   LO
   TS
CP0003248
1-hydroxy-3,4-bis(1-methylindol-3-yl)pyrrole-2,5-dione
   Show/Hide
C22H17N3O3
 1
1
IC50 > 10000 nM
   TI
   LI
   LO
   TS
CP0003433
(Arylindolyl)maleimide deriv. 27
   Show/Hide
C21H16N4O2
 1
1
IC50 > 10000 nM
   TI
   LI
   LO
   TS
CP0003434
1-hydroxy-3-(1H-indol-3-yl)-4-(1-methylindol-3-yl)pyrrole-2,5-dione
   Show/Hide
C21H15N3O3
 1
1
IC50 > 10000 nM
   TI
   LI
   LO
   TS
CP0003435
3-(1-ethylindol-3-yl)-1-hydroxy-4-(1-propan-2-ylindol-3-yl)pyrrole-2,5-dione
   Show/Hide
C25H23N3O3
 1
1
IC50 > 10000 nM
   TI
   LI
   LO
   TS
CP0006368
1-hydroxy-3-(1H-indol-3-yl)-4-(1H-pyrrolo[2,3-b]pyridin-3-yl)pyrrole-2,5-dione
   Show/Hide
C19H12N4O3
 1
1
IC50 > 10000 nM
   TI
   LI
   LO
   TS
CP0006369
6-[3-[4-[1-(5-cyanopentyl)indol-3-yl]-1-hydroxy-2,5-dioxopyrrol-3-yl]indol-1-yl]hexanenitrile
   Show/Hide
C32H31N5O3
 1
1
IC50 > 10000 nM
   TI
   LI
   LO
   TS
CP0006646
4-hydroxy-4,14,21-triazahexacyclo[19.6.1.17,14.02,6.08,13.022,27]nonacosa-1(28),2(6),7(29),8,10,12,22,24,26-nonaene-3,5-dione
   Show/Hide
C26H23N3O3
 1
1
IC50 > 10000 nM
   TI
   LI
   LO
   TS
CP0010066
6-[3-[4-[1-(5-cyanopentyl)indol-3-yl]-2,5-dioxopyrrol-3-yl]indol-1-yl]hexanenitrile
   Show/Hide
C32H31N5O2
 1
1
IC50 > 10000 nM
   TI
   LI
   LO
   TS
CP0010481
3-(1-ethylindol-3-yl)-1-hydroxy-4-(1-methylindol-3-yl)pyrrole-2,5-dione
   Show/Hide
C23H19N3O3
 1
1
IC50 > 10000 nM
   TI
   LI
   LO
   TS
CP0013010
1-hydroxy-3-(1H-indol-3-yl)-4-(1-propan-2-ylindol-3-yl)pyrrole-2,5-dione
   Show/Hide
C23H19N3O3
 1
1
IC50 > 10000 nM
   TI
   LI
   LO
   TS
CP0013451
6-[3-[1-hydroxy-4-(1H-indol-3-yl)-2,5-dioxopyrrol-3-yl]indol-1-yl]hexanoic acid
   Show/Hide
C26H23N3O5
 1
1
IC50 > 10000 nM
   TI
   LI
   LO
   TS
Biochemical Assays
Compound ID Compound Name Compound Formula
CP0095082
DABRAFENIB
   Show/Hide
C23H20F3N5O2S2
 1
1 IC50 = 2 nM